The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

Human Reproduction

Volumn 25, Issue 2, 2010, Pages 544-551

  March, Wendy A ^a,b   Moore, Vivienne M ^b   Willson, Kristyn J ^a   Phillips, David I W ^c   Norman, Robert J ^a   Davies, Michael J ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Endocrine disorder; Hirsutism; Menstrual irregularity; Polycystic ovary syndrome; Rotterdam criteria

Indexed keywords

ADULT; ADULTHOOD; AGE DISTRIBUTION; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COHORT ANALYSIS; COMMUNITY SAMPLE; FEMALE; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; MENSTRUATION DISORDER; NATIONAL HEALTH ORGANIZATION; OVARY POLYCYSTIC DISEASE; PREVALENCE; RETROSPECTIVE STUDY;

EID: 74549160893     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep399     Document Type: Article

References (32)

1. Amowitz LL, Sobel BE. Cardiovascular consequences of polycystic ovary syndrome. Endocrinol Metab Clin North Am 1999;28:439-458.
2. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-2438.
3. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749.
4. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006;91:4237-4245.
5. Balen A, Michelmore K. What is polycystic ovary syndrome? Are national views important? Hum Reprod 2002;17:2219-2227.
6. Balen AH, Laven JSE, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003;9:505-514.
7. Broekmans FJ, Knauff EAH, Valkenburg O, Laven JS, Eijkemans MJ, Fauser B. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006;113:1210-1217.
8. Chang RJ. A practical approach to the diagnosis of polycystic ovary syndrome. Am J Obstet Gynecol 2004;191:713-717.
9. Chen XL, Yang DZ, Mo YQ, Li L, Chen YX, Huang YH. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol 2008;139:59-64.
10. Cresswell JL, Barker DJ, Osmond C, Egger P, Phillips DI, Fraser RB. Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet 1997;350:1131-1135.
11. Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G. Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 2003;18:1928-1932.
12. Dahlgren E, Friberg LG, Johansson S, Lindstrom B, Oden A, Samsioe G, Janson PO. Endometrial carcinoma; ovarian dysfunction-a risk factor in young women. Eur J Obstet Gynecol Reprod Biol 1991;41:143-150.
13. DeUgarte CM, Woods KS, Bartolucci AA, Azziz R. Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism. J Clin Endocrinol Metab 2006;91:1345-1350.
14. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006-4011.
15. Dokras A. Cardiovascular disease risk factors in polycystic ovary syndrome. Semin Reprod Med 2008;26:39-44.
16. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. J Am Med Assoc 2002; 288:1723-1727.
17. Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism-implications, etiology, and management. Am J Obstet Gynecol 1981;140:815-830.
18. Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane D. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria. Am J Obstet Gynecol 2008;198:670.e1-670.e10.
19. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
20. Kumarapeli V, Seneviratne RD, Wijeyaratne CN, Yapa R, Dodampahala SH. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semiurban population in Sri Lanka. Am J Epidemiol 2008;168:321-328.
21. Lowe P, Kovacs G, Howlett D. Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia. Aust N Z J Obstet Gynaecol 2005;45:17-19.
22. McLennan W. Census of Population and Housing: Socioeconomic Indexes for Areas (Catalogue No. 2039.0). Canberra, Australia: Australian Bureau of Statistics, 1998.
23. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 1999;51:779-786.
24. Mulders A, Kate-Booij MT, Pal R, De Kruif M, Nekrui L, Oostra BA, Fauser BCJM, Laven JSE. Influence of oral contraceptive pills on phenotype expression in women with polycystic ovary syndrome. Reprod Biomed Online 2005;11:690-695.
25. Polson DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries-a common finding in normal women. Lancet 1988;1:870-872.
26. Razak F, Anand S, Vuksan V, Davis B, Jacobs R, Teo KK, Yusuf S. Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study. Int J Obes (Lond) 2005;29:656-667.
27. Somunkiran A, Yavuz T, Yucel O, Ozdemir I. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2007;134:196-201.
28. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks relatedtopolycystic ovarysyndrome. Fertil Steril 2004;81:19-25.
29. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-3672.
30. Wild RA, Vesely S, Beebe L, Whitsett T, Owen W. Ferriman Gallwey self-scoring I: performance assessment in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:4112-4114.
31. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Dunaif AGJ, Haseltine F (eds). Polycystic Ovary Syndrome. Boston: Blackwell Scientific, 1992, 377-384.
32. Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB. Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 2002;76:743-749.